142 related articles for article (PubMed ID: 10563332)
21. The binding of glucosylceramidase to glucosylceramide is promoted by its activator protein.
Vaccaro AM; Muscillo M; Salvioli R; Tatti M; Gallozzi E; Suzuki K
FEBS Lett; 1987 Jun; 216(2):190-4. PubMed ID: 3582671
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
Schmid B; Paton BC; Sandhoff K; Harzer K
Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229
[TBL] [Abstract][Full Text] [Related]
23. Properties of a protein activator of glycosphingolipid hydrolysis isolated from the liver of a patient with GM1 gangliosidosis, type 1.
Inui K; Wenger DA
Biochem Biophys Res Commun; 1982 Mar; 105(2):745-51. PubMed ID: 6807306
[No Abstract] [Full Text] [Related]
24. Glycolipid-binding proteins.
Sasaki T
Chem Phys Lipids; 1985 Aug; 38(1-2):63-77. PubMed ID: 4064224
[TBL] [Abstract][Full Text] [Related]
25. Glycosphingolipid specificity of the human sulfatide activator protein.
Vogel A; Schwarzmann G; Sandhoff K
Eur J Biochem; 1991 Sep; 200(2):591-7. PubMed ID: 1889421
[TBL] [Abstract][Full Text] [Related]
26. Biochemistry of glycosphingolipid degradation.
Sandhoff K; Kolter T
Clin Chim Acta; 1997 Oct; 266(1):51-61. PubMed ID: 9435988
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of glycolipids: the role of glycolipid-binding proteins in the function and pathobiochemistry of lysosomes.
Sandhoff K; van Echten G; Schröder M; Schnabel D; Suzuki K
Biochem Soc Trans; 1992 Aug; 20(3):695-9. PubMed ID: 1426613
[No Abstract] [Full Text] [Related]
28. Activator proteins for lysosomal glycolipid hydrolysis.
Conzelmann E; Sandhoff K
Methods Biochem Anal; 1987; 32():1-23. PubMed ID: 3553853
[No Abstract] [Full Text] [Related]
29. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.
Conzelmann E; Burg J; Stephan G; Sandhoff K
Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531
[TBL] [Abstract][Full Text] [Related]
30. Binding of GM1 ganglioside to a synthetic peptide derived from the lysosomal sphingolipid activator protein saposin B.
Champagne MJ; Lamontagne S; Potier M
FEBS Lett; 1994 Aug; 349(3):439-41. PubMed ID: 8050611
[TBL] [Abstract][Full Text] [Related]
31. Binding of GM1-ganglioside to a synthetic peptide derived from the lysosomal sphingolipid-activator-protein saposin B.
Champagne MJ; Lamontagne S; Potier M
FEBS Lett; 1994 Jun; 347(2-3):265-7. PubMed ID: 8034015
[TBL] [Abstract][Full Text] [Related]
32. Interaction of saposins, acidic lipids, and glucosylceramidase.
Morimoto S; Kishimoto Y; Tomich J; Weiler S; Ohashi T; Barranger JA; Kretz KA; O'Brien JS
J Biol Chem; 1990 Feb; 265(4):1933-7. PubMed ID: 2298731
[TBL] [Abstract][Full Text] [Related]
33. [Disorders of sphingolipid activator proteins].
Suzuki Y
Nihon Rinsho; 1995 Dec; 53(12):3025-7. PubMed ID: 8577053
[TBL] [Abstract][Full Text] [Related]
34. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT
J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631
[TBL] [Abstract][Full Text] [Related]
35. Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiency.
Rafi MA; Amini S; Zhang XL; Wenger DA
Am J Hum Genet; 1992 Jun; 50(6):1252-8. PubMed ID: 1350885
[TBL] [Abstract][Full Text] [Related]
36. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
[TBL] [Abstract][Full Text] [Related]
37. Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins.
Linke T; Wilkening G; Sadeghlar F; Mozcall H; Bernardo K; Schuchman E; Sandhoff K
J Biol Chem; 2001 Feb; 276(8):5760-8. PubMed ID: 11104761
[TBL] [Abstract][Full Text] [Related]
38. Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.
Wilkening G; Linke T; Sandhoff K
J Biol Chem; 1998 Nov; 273(46):30271-8. PubMed ID: 9804787
[TBL] [Abstract][Full Text] [Related]
39. Low molecular weight proteins in secondary lysosomes as activators of different sphingolipid hydrolases.
Mraz W; Fischer G; Jatzkewitz H
FEBS Lett; 1976 Aug; 67(1):104-9. PubMed ID: 8337
[No Abstract] [Full Text] [Related]
40. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
